Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Millennium, Wyeth-Ayerst identify another CNS gene target

July 28, 1998

AxyS elucidates 3-D structure of cathepsin S

July 27, 1998

Fuisz and AHP agreement for CEFORM EA technology

July 24, 1998

Genzyme Transgenics and Lilly to develop novel transgenic protein

July 24, 1998

AxyS, Signal announce drug discovery collaboration

July 24, 1998

StressGen establishes multiinstitutional collaboration for stress protein-modulating drugs

July 21, 1998

OSI receives patent protection for its gene transcription-regulating drugs

July 20, 1998

Trega identifies lead compounds in R&D collaboration with Ono

July 17, 1998

Bioject enters vaccine delivery agreement with Merck

July 17, 1998

Nexell's Isolex technology receives U.S. patent protection; FDA requests more data

July 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...